Redmond Asset Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-65,136
| Closed | -$275K | – | 173 |
|
|
2022
Q3 | $275K | Sell |
65,136
-253
| -0.4% | -$1.07K | 0.1% | 150 |
|
|
2022
Q2 | $182K | Sell |
65,389
-4,370
| -6% | -$12.2K | 0.07% | 175 |
|
|
2022
Q1 | $399K | Buy |
69,759
+23,736
| +52% | +$136K | 0.12% | 160 |
|
|
2021
Q4 | $420K | Sell |
46,023
-5,224
| -10% | -$47.7K | 0.12% | 163 |
|
|
2021
Q3 | $548K | Hold |
51,247
| – | – | 0.17% | 146 |
|
|
2021
Q2 | $795K | Sell |
51,247
-23
| -0% | -$357 | 0.23% | 131 |
|
|
2021
Q1 | $831K | Buy |
51,270
+155
| +0.3% | +$2.51K | 0.26% | 124 |
|
|
2020
Q4 | $1.08M | Buy |
51,115
+4,625
| +10% | +$97.9K | 0.38% | 89 |
|
|
2020
Q3 | $689K | Buy |
46,490
+172
| +0.4% | +$2.55K | 0.29% | 112 |
|
|
2020
Q2 | $681K | Sell |
46,318
-217
| -0.5% | -$3.19K | 0.28% | 104 |
|
|
2020
Q1 | $546K | Buy |
46,535
+689
| +2% | +$8.08K | 0.27% | 107 |
|
|
2019
Q4 | $1.08M | Buy |
45,846
+211
| +0.5% | +$4.96K | 0.46% | 73 |
|
|
2019
Q3 | $844K | Buy |
45,635
+68
| +0.1% | +$1.26K | 0.37% | 87 |
|
|
2019
Q2 | $847K | Buy |
45,567
+436
| +1% | +$8.1K | 0.36% | 94 |
|
|
2019
Q1 | $1.1M | Buy |
+45,131
| New | +$1.1M | 0.48% | 76 |
|